Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) shares traded down 0.4% on Thursday. The stock traded as low as C$4.77 and last traded at C$4.81. 49,621 shares were traded during mid-day trading, an increase of 6% from the average daily volume of 46,847 shares. The stock had previously closed at C$4.83.
Medexus Pharmaceuticals Stock Performance
The stock has a market capitalization of C$153.99 million, a PE ratio of -70.00 and a beta of 0.71. The stock has a 50-day moving average price of C$5.06 and a two-hundred day moving average price of C$4.55.
Medexus Pharmaceuticals Company Profile
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Further Reading
- Five stocks we like better than Medexus Pharmaceuticals
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
